HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Genetic background of acute anterior uveitis.

Abstract
To determine the hereditary pattern of acute anterior uveitis, we examined seven families-one family with four cases, one family with three cases, and four families with two cases of acute anterior uveitis. A total of 16 patients with uveitis and 28 relatives underwent ocular examinations and serologic determination of HLA antigens, protease inhibitor alpha 1-antitrypsin typing, and X-ray examination of sacroiliac joints. Sacroiliitis was found in 11 of 16 patients (68.8%) and incomplete Reiter's disease in seven of 16 (43.8%). HLA-B27 antigen was found in all patients with uveitis and in six of 21 (28.6%) relatives. HLA-Cw1 antigen was found in nine of 14 (64.3%) patients with uveitis, often in the same haplotype with HLA-B27 antigen. HLA-DR4 antigen was found in seven of 11 (63.6%) patients with uveitis. There was no significant association of the alpha 1-antitrypsin variant MZ with uveitis. We believe that a pleiotropic gene associated with HLA-B27 antigen with autosomal dominant inheritance, incomplete penetrance, and variable expressivity may determine susceptibility to acute anterior uveitis in linkage disequilibrium with HLA-Cwl antigen.
AuthorsA Tiilikainen, S Koskimies, A Eriksson, R Frants
JournalAmerican journal of ophthalmology (Am J Ophthalmol) Vol. 91 Issue 6 Pg. 711-20 (Jun 1981) ISSN: 0002-9394 [Print] United States
PMID6972700 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • HLA Antigens
  • alpha 1-Antitrypsin
Topics
  • Acute Disease
  • Adult
  • Aged
  • Arthritis, Reactive (diagnosis)
  • Female
  • HLA Antigens (analysis)
  • Humans
  • Inflammation
  • Male
  • Middle Aged
  • Pedigree
  • Radiography
  • Sacroiliac Joint (diagnostic imaging)
  • Uveitis (genetics)
  • alpha 1-Antitrypsin (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: